Structural and inhibitor studies of norovirus 3C-like proteases

Virus Research

Volumn 178, Issue 2, 2013, Pages 437-444

  Takahashi, Daisuke ^a   Kim, Yunjeong ^a   Lovell, Scott ^b   Prakash, Om ^a   Groutas, William C ^c   Chang, Kyeong Ok ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c WICHITA STATE UNIVERSITY   (United States)

Author keywords

3C like protease; 3D structures; Inhibitors; Norovirus

Indexed keywords

3C LIKE CYSTEINE PROTEASE; CYSTEINE PROTEINASE; GC 376; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG BINDING; ENZYME INHIBITION; ENZYME STRUCTURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; NONHUMAN; NOROVIRUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; X RAY CRYSTALLOGRAPHY;

MURINE NOROVIRUS 1; NOROVIRUS; NORWALK VIRUS;

3C-LIKE PROTEASE; 3D STRUCTURES; INHIBITORS; NOROVIRUS;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY, X-RAY; CYSTEINE ENDOPEPTIDASES; FLUORESCENCE RESONANCE ENERGY TRANSFER; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; NOROVIRUS; PROTEASE INHIBITORS; PROTEIN BINDING; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; VIRAL PROTEINS;

EID: 84888200639     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.09.008     Document Type: Article

References (34)

1. Atmar R.L., Bernstein D.I., Harro C.D., Al-Ibrahim M.S., Chen W.H., Ferreira J., Estes M.K., Graham D.Y., Opekun A.R., Richardson C., Mendelman P.M. Norovirus vaccine against experimental human Norwalk virus illness. N. Engl. J. Med. 2011, 365(23):2178-2187.
2. CDC, 2010. http://www.cdc.gov/ncidod/dvrd/revb/gastro/norovirus-factsheet.htm.
3. Chang K.O., Takahashi D., Prakash O., Kim Y. Characterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assay. Virology 2012, 423(2):125-133.
4. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6(3):277-293.
5. Desai R., Hembree C.D., Handel A., Matthews J.E., Dickey B.W., McDonald S., Hall A.J., Parashar U.D., Leon J.S., Lopman B. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin. Infect. Dis. 2012, 55(2):189-193.
6. Dou D., He G., Mandadapu S.R., Aravapalli S., Kim Y., Chang K.O., Groutas W.C. Inhibition of noroviruses by piperazine derivatives. Bioorg. Med. Chem. Lett. 2011, 22(1):377-379.
7. Dou D., Mandadapu S.R., Alliston K.R., Kim Y., Chang K.O., Groutas W.C. Design and synthesis of inhibitors of noroviruses by scaffold hopping. Bioorg. Med. Chem. 2011, 19(19):5749-5755.
8. Dou D., Mandadapu S.R., Alliston K.R., Kim Y., Chang K.O., Groutas W.C. Cyclosulfamide-based derivatives as inhibitors of noroviruses. Eur. J. Med. Chem. 2012, 47(1):59-64.
9. Dou D., Tiew K.C., He G., Mandadapu S.R., Aravapalli S., Alliston K.R., Kim Y., Chang K.O., Groutas W.C. Potent inhibition of Norwalk virus by cyclic sulfamide derivatives. Bioorg. Med. Chem. 2011, 19(20):5975-5983.
10. Eckardt A.J., Baumgart D.C. Viral gastroenteritis in adults. Recent Pat. Antiinfect. Drug Discov. 2011, 6(1):54-63.
11. Goddard T.D., Kneller D.G. SPARKY 3.113 2006, University of California, San Francisco, CA.
12. Green K.Y. Caliciviruses: the noroviruses. Fields Virology 2007, 1:949-980. Lippincott Williams & Wilkins, Philadelphia, PA. fifth ed.
13. Grzesiek S., Bax A., Clore G.M., Gronenborn A.M., Hu J.S., Kaufman J., Palmer I., Stahl S.J., Wingfield P.T. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat. Struct. Biol. 1996, 3(4):340-345.
14. Hussey R.J., Coates L., Gill R.S., Erskine P.T., Coker S.F., Mitchell E., Cooper J.B., Wood S., Broadbridge R., Clarke I.N., Lambden P.R., Shoolingin-Jordan P.M. A structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor. Biochemistry 2011, 50:240-249.
15. Keller R.L.J. The Computer Aided Resonance Assignment Tutorial 2004, CANTINA Verlag, Goldau, Switzerland.
16. Kim Y., Lovell S., Tiew K.C., Mandadapu S.R., Alliston K.R., Battaile K.P., Groutas W.C., Chang K.O. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J. Virol. 2012, 86(21):11754-11762.
17. Kim Y., Thapa M., Hua D.H., Chang K.O. Biodegradable nanogels for oral delivery of interferon for norovirus infection. Antiviral Res. 2011, 89(2):165-173.
18. Koo H.L., Ajami N., Atmar R.L., DuPont H.L. Noroviruses: the leading cause of gastroenteritis worldwide. Discov. Med. 2010, 10(50):61-70.
19. Leen E.N., Baeza G., Curry S. Structure of a murine norovirus NS6 protease-product complex revealed by adventitious crystallisation. PLoS One 2012, 7(6):e38723.
20. Mandadapu S.R., Gunnam M.R., Tiew K.C., Uy R.A., Prior A.M., Alliston K.R., Hua D.H., Kim Y., Chang K.O., Groutas W.C. Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors. Bioorg. Med. Chem. Lett. 2013, 23(1):62-65.
21. Mandadapu S.R., Weerawarna P.M., Gunnam M.R., Alliston K.R., Kim Y., Chang K.O., Groutas W.C. Potent inhibition of Norwalk virus 3C protease by peptidyl α-ketoamides and α-ketoheterocycles. Bioorg. Med. Chem. 2012, 22:4820-4826.
22. Mandadapu S.R., Weerawarna P.M., Prior A.M., Uy R.A.Z., Aravapalli S., Alliston K.R., Lushington G.H., Kim Y., Hua D.H., Chang K.-O., Groutas W.C. Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus. Bioorg. Med. Chem. Lett. 2013, 23:3709-3712.
23. MMWR Notes from the Field: Emergence of New Norovirus Strain GII.4 Sydney-United States 2012 2013, 03:55-62.
24. Nakamura K., Someya Y., Kumasaka T., Ueno G., Yamamoto M., Sato T., Takeda N., Miyamura T., Tanaka N. A norovirus protease structure provides insights into active and substrate binding site integrity. J. Virol. 2005, 79(21):13685-13693.
25. Patel M.M., Hall A.J., Vinje J., Parashara U.D. Noroviruses: a comprehensive review. J. Clin. Virol. 2009, 44(1):1-8.
26. Pokhrel L., Kim Y., Nguyen T.D., Prior A.M., Lu J., Chang K.O., Hua D.H. Synthesis and anti-norovirus activity of pyranobenzopyrone compounds. Bioorg. Med. Chem. Lett. 2012, 22(10):3480-3484.
27. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 1967, 27(2):157-162.
28. Shuker S.B., Hajduk P.J., Meadows R.P., Fesik S.W. Discovering high-affinity ligands for proteins: SAR by NMR. Science 1996, 274(5292):1531-1534.
29. Takahashi D., Hiromasa Y., Kim Y., Anbanandam A., Yao X., Chang K.O., Prakash O. Structural and dynamics characterization of norovirus protease. Protein Sci. 2013, 22(3):347-357.
30. Takahashi D., Kim Y., Chang K.O., Anbanandam A., Prakash O. Backbone and side-chain (1)H (1)(5)N, and (1)(3)C resonance assignments of Norwalk virus protease. Biomol. NMR Assign. 2012, 6(1):19-21.
31. Tan M., Jiang X. Norovirus gastroenteritis, increased understanding and future antiviral options. Curr. Opin. Investig. Drugs 2008, 9(2):146-151.
32. Tiew K.C., He G., Aravapalli S., Mandadapu S.R., Gunnam M.R., Alliston K.R., Lushington G.H., Kim Y., Chang K.O., Groutas W.C. Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease. Bioorg. Med. Chem. Lett. 2011, 21(18):5315-5319.
33. van Beek J., Ambert-Balay K., Botteldoorn N., Eden J.S., Fonager J., Hewitt J., Iritani N., Kroneman A., Vennema H., Vinje J., White P.A., Koopmans M., NoroNet Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II. 4, late 2012. Euro Surveill. 2013, 18(1):8-9.
34. Zeitler C.E., Estes M.K., Venkataram Prasad B.V. X-ray crystallographic structure of the Norwalk virus protease at 1.5-a resolution. J. Virol. 2006, 80(10):5050-5058.